COVID-19 UPDATE: Few signs wave 1 and wave 2 epicenters seeing "new wave" of cases. 3Q2020 highlighting dramatic operating leverage of "epicenter stocks"

Click HERE to access the FSInsight COVID-19 Daily Chartbook.

STRATEGY: While markets await Election day, signs of operating leverage in 3Q2020Taking stock of 2020 so far, in my opinion, COVID-19 is the most important macro story and in some ways, more important than fiscal stimulus and in some aspects, more important than the Fed (Fed can't cure COVID).  What has been lost in the past few weeks (into 2020 Presidential elections) is that 3Q2020 earnings have been pretty good.  One thing that stands out to us is the growing evidence of operating leverage in the epicenter groups.It has been a rough run for "epicenter" stocks for the past few weeks.  The surge in COVID-19 cases coupled with the delay in fiscal stimulus has weighed heavily.  But we still remain constructive on these stocks, even as the past few weeks have been awful.  Mainly, we see US economic momentum strengthening in 2021, even with COVID-19 still surging in the US (less deadly and lockdowns are not needed here).  And we see additional reasons Cyclicals, aka epicenter, could see surprisingly strong EPS in 2021:- restricted topline environment forces these companies to slash operating costs ala 2008- demand recovery from either stimulus or vaccine = operating leverage- P/E can e...

Unlock this article with a FREE 30-Day Trial!

An FSI Pro, or FSI Macro subscription is required in order to access this content.

*Free trial available only on a monthly plan

More from the author

Disclosures (show)

Get invaluable analysis of the market and stocks. Cancel at any time. Start Free Trial

Articles Read 2/2

🎁 Unlock 1 extra article by joining our Community!

You’ve reached your limit of 2 free monthly articles. Please enter your email to unlock 1 more articles.

Already have an account? Sign In

Don't Miss Out
First Month Free